Product Images Deferasirox

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Deferasirox NDC 72603-233 by Northstar Rx Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

fig1 - deferasirox fig1

fig1 - deferasirox fig1

Figure 1 shows changes in Liver Iron Concentration and Serum Ferritin following Deferasirox Tablets for Oral Suspension at dosages ranging from 5 to 30 mg per kg per day in Study 1. The graph indicates the impact of different dosages on LIC and serum ferritin levels.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 90 mg (30 Tablet Bottle) - deferasirox fig2

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 90 mg (30 Tablet Bottle) - deferasirox fig2

This is a pharmaceutical product containing Deferasirox Tablets with a dosage of 90 mg per film-coated tablet. The tablets are manufactured by APL Healthcare Limited in India for Northstar Ax LLC based in Memphis, TN. The package includes 30 tablets and recommends storing them at 20° to 25°C. Patients are advised to refer to the provided Medication Guide and keep the medication out of reach of children. More information can be found at www.northstarrndic.com/products or by calling 1-800-206-7821.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 180 mg (30 Tablet Bottle) - deferasirox fig3

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 180 mg (30 Tablet Bottle) - deferasirox fig3

This text provides information about Deferasirox tablets, with each film-coated tablet containing 180 mg of the active ingredient. The tablets are manufactured by Northstar Healthcare Holdings Ltd. in Memphis, TN, and distributed by APL Healthcare Limited in Andhra Pradesh, India. The usual dosage instructions are included, along with storage recommendations. Pharmacists are advised to dispense the medication guide to patients separately. The product is from India and the packaging includes a GTIN, serial number, expiry date, and LOT information both in human-readable coding area and 2D printing during packing. Further details can be found on the Northstar Healthcare website or by calling 1-800-206-7621.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 360 mg (30 Tablet Bottle) - deferasirox fig4

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 360 mg (30 Tablet Bottle) - deferasirox fig4

The text contains information on Deferasirox 360 mg tablets manufactured in Memphis, TN. It provides dosage instructions, storage guidelines, contact details, and references to medication guides. The tablets are stored at controlled room temperature and are manufactured in Andhra Pradesh, India. Patients are advised to keep drugs out of reach of children and protect them from moisture. The information includes a provision for dispensing a medication guide to each patient.*

CHEMICAL STRUCTURE - deferasirox str

CHEMICAL STRUCTURE - deferasirox str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.